Two Grants Fund Studies of Therapy Options to Treat LAM and Triple Negative Breast Cancer
Researchers to Study Diabetes Self-Management and Behavioral Interventions More than 25 million Americans have diabetes, yet as many as 60 percent of type 2 diabetes patients do not follow treatment plans prescribed by their health care provider and about 50 percent fail to meet treatment recommendations for control of blood glucose levels. Consistent adherence to…
Einstein-Montefiore Researchers Secure $16 Million NIH Grant to Study HIV/AIDS in Women
Dr. Marina Holz, assistant professor of biology at Stern College for Women, has received an NIH Academic Research Enhancement Award (AREA) R15 grant for identification and characterization of S6 Kinase 1 (S6K1) targets in mammary cell proliferation. S6K1 is a therapeutic target in breast cancer treatment.
The National Institutes of Health (NIH) has awarded Albert Einstein College of Medicine of Yeshiva University two grants totaling $3.5 million to study epigenetic changes—chemical modifications of genes caused by stress, diet or other environmental influences—and how they contribute to human diseases and biological processes.
The National Institutes of Health (NIH) has awarded Albert Einstein College of Medicine of Yeshiva University a five-year, $11.2 million grant to study the impact of damage to DNA on aging and disease. Research funded by this grant, and conducted by a consortium of scientists, could reveal the role of genome maintenance systems in delaying aging and will begin to explore novel interventions to maintain health in old age.
Aug 31, 2009 — Dr. Jonathan Feldman, assistant professor at Ferkauf Graduate School of Psychology, is the co-recipient of a $2.5 million grant from the National Institute of Health’s National Center for Complementary and Alternative Medicine to study ethnic disparities in childhood asthma. The grant is shared with researchers at Arizona State University. Research will…
The National Institute on Drug Abuse of the National Institutes of Health has awarded a three-year, $3-million grant to Albert Einstein College of Medicine of Yeshiva University to establish a research center to study the neurological complications that afflict people infected with HIV, the virus that causes AIDS.
A consortium of research centers in the tri-state region, including Yeshiva University’s Albert Einstein College of Medicine, has received a $46 million grant to conduct research on emerging infectious diseases.
Albert Einstein College of Medicine of Yeshiva University has been awarded a grant of more than $9.25 million from the National Institutes of Health to further the medical school’s study of centenarians and the biology of aging.